Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow
the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. Radiation
therapy uses high-energy x-rays to damage tumor cells. Monoclonal antibodies can locate tumor
cells and either kill them or deliver tumor-killing substances to them without harming normal
cells.
PURPOSE: Phase II trial to study the effectiveness of combining chemotherapy, radiation
therapy, immunotherapy, and bone marrow transplantation in treating patients with
neuroblastoma.